Nexalin Technology, Inc.(the "Company" or "Nexalin")(NASDAQ:NXL, NXLIW)today announced that Company's abstract, titled: "MEG Source Imaging Reveals Neuronal Changes in Combat-Related Mild Traumatic Brain Injury after Transcranial Electrical Stimulation using Nexalin," has been accepted for a poster presentation at the upcoming 2023 Military Health System Research Symposium (MHSRS) being held on August 14-17, 2023 at the Gaylord Palms Resort and Convention Center, Kissimmee, Florida, USA.
The abstract was accepted under the breakout session: Mental Health and Traumatic Brain Injury. The poster for this breakout session will be presented in Poster Session 2 on Tuesday, August 15, 2023. The poster will be...